CDT CDT Equity Inc.
$0.25▼ -27.49%
Healthcare
Other
After hours
$0.24▼ -5.96%
Sep 11, 7:59 PM ET
Volume 9.55M
Avg Volume (10D) 5.14M
Key Metrics & Fundamentals
Market Cap
$3.42M
P/E Ratio
–
Div Yield
–%
52W Range
0.23 - 2360.00
% vs 50 MA
-90.91%
% vs 200 MA
-99.81%
RSI-14
17.8
MACD Histogram
-0.0700
Beta (1Y vs SPY)
2.18
Free Cash Flow
-$544,000
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.08M
COGS
–
Operating Exp
$3.00M
Operating Income
-$3.00M
EBIT
-$3.00M
Pretax Income
-$4.64M
Net Income
-$4.64M
EPS (Diluted)
-87.10
Price & Volume History
Loading chart…
Recent News
CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health
GlobeNewswire · Sep 10, 2026 11:00 AM
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
GlobeNewswire · Sep 2, 2026 9:00 AM
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
GlobeNewswire · Sep 1, 2026 12:00 PM
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
GlobeNewswire · Aug 28, 2026 9:00 AM
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
GlobeNewswire · Aug 25, 2026 9:00 AM
CDT Equity to Boost Stake in Sarborg
MT Newswires · Aug 3, 2026 4:42 PM
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
GlobeNewswire · Aug 3, 2026 12:30 PM
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
GlobeNewswire · Jul 20, 2026 12:30 PM
CDT Equity Implements 1-for-10 Reverse Stock Split
MT Newswires · Jul 16, 2026 12:18 PM
CDT Equity Inc. Announces Reverse Stock Split
GlobeNewswire · Jul 16, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CDT's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.